Bausch Health Companies Stock Analysis
BHC Stock | USD 6.57 0.06 0.92% |
Bausch Health Companies is fairly valued with Real Value of 6.61 and Target Price of 7.08. The main objective of Bausch Health stock analysis is to determine its intrinsic value, which is an estimate of what Bausch Health Companies is worth, separate from its market price. There are two main types of Bausch Health's stock analysis: fundamental analysis and technical analysis.
The Bausch Health stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bausch Health's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Bausch Stock Analysis Notes
About 69.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.63. Bausch Health Companies recorded a loss per share of 0.12. The entity last dividend was issued on the 10th of November 2010. The firm had 2:1 split on the 16th of October 2000. Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. is headquartered in Laval, Canada. Bausch Health is traded on New York Stock Exchange in the United States. For more info on Bausch Health Companies please contact Joseph Papa at 514 744 6792 or go to https://www.bauschhealth.com.Bausch Health Quarterly Total Revenue |
|
Bausch Health Companies Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bausch Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health Companies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the last year's revenue of 9.52 B. Reported Net Loss for the year was (72 M) with profit before taxes, overhead, and interest of 6.89 B. | |
Bausch Health has a strong financial position based on the latest SEC filings | |
About 69.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from news.google.com: What analysts say about Bausch Health Companies Inc. stock - Tremendous return on equity - jammulinksnews.com |
Bausch Health Companies Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bausch Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024 Upcoming Quarterly Report | View | |
2nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Bausch Largest EPS Surprises
Earnings surprises can significantly impact Bausch Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1997-02-27 | 1996-12-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2001-04-26 | 2001-03-31 | 0.18 | 0.2 | 0.02 | 11 | ||
1996-07-17 | 1996-06-30 | 0.04 | 0.06 | 0.02 | 50 |
Bausch Health Environmental, Social, and Governance (ESG) Scores
Bausch Health's ESG score is a quantitative measure that evaluates Bausch Health's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Bausch Health's operations that may have significant financial implications and affect Bausch Health's stock price as well as guide investors towards more socially responsible investments.
Bausch Stock Institutional Investors
Shares | Hudson Bay Capital Management Lp | 2025-03-31 | 5 M | Ing Groep Nv | 2025-03-31 | 5 M | Franklin Resources Inc | 2025-03-31 | 4.3 M | Arrowstreet Capital Limited Partnership | 2025-03-31 | 4.3 M | Dimensional Fund Advisors, Inc. | 2025-03-31 | 3.1 M | Bnp Paribas Arbitrage, Sa | 2025-03-31 | 3 M | Sg Americas Securities, Llc | 2025-03-31 | 2.9 M | Hillsdale Investment Management Inc. | 2025-03-31 | 1.7 M | Private Management Group Inc | 2025-03-31 | 1.4 M | Icahn Carl C | 2025-03-31 | 34.7 M | Goldentree Asset Management Lp | 2025-03-31 | 30.2 M |
Bausch Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 2.41 B.Bausch Profitablity
Last Reported | Projected for Next Year | ||
Return On Capital Employed | 0.08 | 0.10 | |
Return On Equity | 0.03 | 0.03 |
Management Efficiency
Bausch Health Companies has Return on Asset of 0.0431 % which means that on every $100 spent on assets, it made $0.0431 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (23.0454) %, meaning that it generated no profit with money invested by stockholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.10, whereas Return On Tangible Assets are projected to grow to (0). At present, Bausch Health's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 5.8 B, whereas Total Assets are forecasted to decline to about 15.4 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.87) | (0.83) | |
Tangible Book Value Per Share | (46.09) | (48.39) | |
Enterprise Value Over EBITDA | 15.14 | 14.38 | |
Price Book Value Ratio | (2.32) | (2.20) | |
Enterprise Value Multiple | 15.14 | 14.38 | |
Price Fair Value | (2.32) | (2.20) | |
Enterprise Value | 21.9 B | 17.7 B |
Examining the leadership quality of Bausch Health Companies offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Technical Drivers
As of the 23rd of July, Bausch Health shows the Risk Adjusted Performance of 0.1629, mean deviation of 2.57, and Downside Deviation of 3.08. Bausch Health Companies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bausch Health Companies Price Movement Analysis
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Bausch Health Companies price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
Bausch Health Companies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bausch Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bausch Health Outstanding Bonds
Bausch Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bausch Health Companies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bausch bonds can be classified according to their maturity, which is the date when Bausch Health Companies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Bausch Health Predictive Daily Indicators
Bausch Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bausch Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Bausch Health Corporate Filings
F4 | 18th of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 16th of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 15th of July 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 10th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 2nd of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 27th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 18th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
17th of June 2025 Other Reports | ViewVerify |
Bausch Health Forecast Models
Bausch Health's time-series forecasting models are one of many Bausch Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bausch Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bausch Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bausch Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bausch shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bausch Health. By using and applying Bausch Stock analysis, traders can create a robust methodology for identifying Bausch entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.02 | 0.02 | |
Operating Profit Margin | 0.16 | 0.17 | |
Gross Profit Margin | 0.71 | 0.81 |
Current Bausch Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bausch analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bausch analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.08 | Hold | 7 | Odds |
Most Bausch analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bausch stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bausch Health Companies, talking to its executives and customers, or listening to Bausch conference calls.
Bausch Stock Analysis Indicators
Bausch Health Companies stock analysis indicators help investors evaluate how Bausch Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bausch Health shares will generate the highest return on investment. By understating and applying Bausch Health stock analysis, traders can identify Bausch Health position entry and exit signals to maximize returns.
Begin Period Cash Flow | 962 M | |
Total Stockholder Equity | -1.3 B | |
Property Plant And Equipment Net | 1.8 B | |
Cash And Short Term Investments | 1.2 B | |
Cash | 1.2 B | |
50 Day M A | 5.5994 | |
Net Interest Income | -1.4 B | |
Total Current Liabilities | 6.8 B | |
Forward Price Earnings | 1.7325 | |
Interest Expense | 1.4 B | |
Stock Based Compensation | 150 M | |
Long Term Debt | 18.9 B | |
Common Stock Shares Outstanding | 368 M | |
Total Cashflows From Investing Activities | -454 M | |
Tax Provision | 239 M | |
Quarterly Earnings Growth Y O Y | -0.612 | |
Accounts Payable | 656 M | |
Net Debt | 20.4 B | |
Other Operating Expenses | 8.1 B | |
Non Current Assets Total | 20.7 B | |
Liabilities And Stockholders Equity | 26.5 B | |
Non Currrent Assets Other | 363 M |
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |